Ra Capital Management Lowers Stake in Derma Sciences Inc (DSCI)

Peter Kolchinsky‘s Ra Capital Management has recently sold a total of 300,000 shares of Derma Sciences Inc (NASDAQ:DSCI). Following the disposal, the fund still holds a significant amount of over 1.69 million shares of the company. According to the filing with the SEC, Ra Capital sold the securities in two transactions, the average price amounting to $11.83 per share.

Peter Kolchinsky

The shares have been sold entirely from the account owned by Blackwell Partners, LLC, the filing also stated. According to the amount of shares disclosed by Derma Sciences Inc (NASDAQ:DSCI) in its latest 10-Q report, the stake held by Ra Capital amasses around 9.8% of the common stock, following the disposal of shares.

Medical technology company Derma Sciences Inc (NASDAQ:DSCI) is engaged in the wound care marketplace. Today, on January 14, the company announced about licensing exclusive rights for two products from BioD LLC. The products will be launched later this year and will expand Derma Sciences’ portfolio of wound care products.

Meanwhile, the stock of Derma Sciences Inc (NASDAQ:DSCI) remained basically flat over the past year. The company significantly expanded its net loss for the first nine months of 2013, which amounted to $18.54 million, versus $8.39 million. For the full year, analysts expect the company to post an EPS of -$1.47, which is significantly lower with comparison to -$0.27 posted in 2012.

Last month, Kevin Kotler‘s Broadfin Capital has raised its stake in Derma Sciences Inc (NASDAQ:DSCI). The fund disclosed ownership of 871,600 shares, up from  771,600 held earlier. Overall, Broadfin’s stake amasses 5.04% of the company’s common stock. At the same time, in the latest round of 13F filings, Baker Bros. Advisors, led by Julian Baker and Felix Baker reported a larger stake, which amasses 2.56 million shares, being increased by almost 90% during the third quarter.

On the other hand, in November, Peter Kolchinsky’s fund reported upping its position in Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN). Currently, the fund holds some 23.4 million shares, which has been raised, in several transactions from 14.46 million disclosed by the fund in its latest 13F.

Disclosure: none

Recommended Reading:

Litespeed Management LLC Initiates Stake in FTD Companies Inc (FTD)

What you can Learn from a Hedge Fund Blog

Farallon Capital Management Adds Sycamore Networks Inc. (SCMR) To Its Equity Portfolio

blog comments powered by Disqus
Insider Monkey Headlines
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months Click to see monthly returns in table format!

Lists

5 Retirement Mistakes To Avoid (and Einstein’s Famous Quote)

11 Smartest People in the World

6 Films About the Financial World You Need To Watch (While “The Wolf” is Not Around)

Warren Buffett and Billionaires Are Crazy About These 7 Stocks

The Top 10 States With Fastest Internet Speeds

10 Best Places to Visit in USA in August

Top 10 Cities to Visit Before You Die

Top 10 Genetically Modified Food In the US

15 Highest Grossing Movies Opening Weekend

5 Best Poker Books For Beginners

10 Strategies Hedge Funds Use to Make Huge Returns

Top 10 Fast Food Franchises to Buy

10 Best Places to Visit in Canada

Best Summer Jobs for Teachers

10 Youngest Hedge Fund Billionaires

Top 10 One Hit Wonders of the 90s

Fastest Growing Cities In America

Top 10 U.S. Cities for Freelancers

Top 9 Most Popular Free iPhone Apps

Top 10 Least Expensive Private Business Schools in the US

Top 15 Most Expensive Countries in the World – 2014

Top Businesses to Invest In

Top 5 Things You Might Be Doing Wrong With Your Business

Top 5 Strategic Technology Trends in 2014

Top Rags to Riches Stories

Parenting Behavior That Promotes Future Leaders

Top 5 Mistakes Made by Small Businesses

Top 5 Most Common and Potentially Devastating Financial Blunders

Top 5 Highest Paying Jobs for Web Designers

Top 6 Most Respected Professions that Also Pay Well

Top 5 Pitfalls Investors Should Avoid

Top 6 Lawyers and Policy Makers Under 30

Top 6 New Year’s Resolutions for Entrepreneurs

Top 7 Locations to Check in on Facebook

Top 5 Mistakes made by Rookie eBay Sellers

Top 7 eBook Publishers in 2013

Top 6 Health Industry Trends in 2014

5 Lessons for Entrepreneurs from Seth Godin

Top 5 Success Tips from Jordan Belfort – the Wolf of Wall Street

Best Master’s in Finance Degree Programs

Top 6 Earning Celebrities Over 50

The most expensive sports to play

Top 7 Earning Celebrities Under 25

Best 7 Online Courses to Take: Free Finance MOOCs

Top 6 Bad Habits that Promote Failure

20 Most Valuable Soccer Teams in the World in 2013

12 Most Expensive Countries for Foreign Students

Top 30 Most Influential Women in the World

Top 20 Most Expensive New Year Eve Shows

Top 5 Best Vocational Careers

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!